Within the next month or so we will be switching gears from the comparatively small-scale trial run of Sisonke to a full-on mass vaccination programme. As with the onset of a new wave of infections, this presents a dramatic shift in the pandemic and our response to it – although in this case, the shift is finally a good thing, writes Spotlight editor Marcus Low.
South Africa is likely headed for a third wave of COVID-19 infections, experts warn. With no windfall of vaccines in sight, many people at high risk of COVID-19 will remain unvaccinated. Now some doctors and medical ethicists are asking: Is a safe vaccine that could possibly protect them better than nothing?
Government deserves criticism for various aspects of its COVID-19 response, but some social media criticism following Sunday’s announcement that the Oxford University/AstraZeneca vaccine has little or no efficacy in preventing mild-to-moderate disease caused by the 501Y.V2 variant has been unfair, writes Marcus Low.
The delivery of a safe and effective COVID-19 vaccine once it becomes available in South Africa will be a complex and costly logistical exercise. Acquiring enough injection devices is part of crucial logistical planning to ensure rapid, equitable access to COVID-19 vaccines. Adele Baleta reports.